Celanese Corp

For the period ended Nov 2, 2026. Filed Nov 2, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 2, 2026 · Filed Nov 2, 2026

CE$46.49-2.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.2 · Table

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited

Q3 '26 · Q2 '26 · Q1 '26 · 2025 · Q4 '25 · Q3 '25 · Q2 '25 · Q1 '25
(In $ millions, except percentages)
Operating Profit (Loss) / Operating Margin
Engineered Materials	161		11.8%	156		10.8%	221	16.7%	(958)	(17.8)%	111	8.7%	(1,327)	(95.9)%	164	11.4%	94	7.3%
Acetyl Chain	141		11.7%	237		17.8%	95	9.2%	539	12.7%	90	9.6%	135	12.7%	153	13.7%	161	14.4%
Other Activities(1)	(104)			(117)			(102)		(367)		(108)		(83)		(86)		(90)
Total	198		7.7%	276		10.0%	214	9.2%	(786)	(8.2)%	93	4.2%	(1,275)	(52.7)%	231	9.1%	165	6.9%
Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials	2			2			2		6		—		3		1		2
Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain	2			2			2		8		3		1		2		2
Operating Profit (Loss) Attributable to Celanese Corporation	194		7.6%	272		9.9%	210	9.0%	(800)	(8.4)%	90	4.1%	(1,279)	(52.9)%	228	9.0%	161	6.7%
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation
Engineered Materials	159		11.6%	154		10.7%	219	16.5%	(964)	(17.9)%	111	8.7%	(1,330)	(96.1)%	163	11.3%	92	7.1%
Acetyl Chain	139		11.5%	235		17.7%	93	9.0%	531	12.5%	87	9.3%	134	12.6%	151	13.5%	159	14.2%
Other Activities(1)	(104)			(117)			(102)		(367)		(108)		(83)		(86)		(90)
Total	194		7.6%	272		9.9%	210	9.0%	(800)	(8.4)%	90	4.1%	(1,279)	(52.9)%	228	9.0%	161	6.7%
Equity Earnings and Dividend Income Attributable to Celanese Corporation
Engineered Materials	3	(2)		6	(2)		31		105		32		33		24		16
Acetyl Chain	47			44			2		131		42		43		43		3
Other Activities(1)	3			4			3		13		3		3		3		4
Total	53			54			36		249		77		79		70		23
Non-Operating Pension, Other Post-Retirement Employee Benefit and Other Income (Expense) Attributable to Celanese Corporation
Engineered Materials	4			(16)			1		7		3		2		1		1
Acetyl Chain	1			—			—		1		—		1		—		—
Other Activities(1)	6			4			5		54		47		3		1		3
Total	11			(12)			6		62		50		6		2		4
Certain Items Attributable to Celanese Corporation (Table 8)
Engineered Materials	43			90			(31)		1,572		37		1,495		25		15
Acetyl Chain	49			42			36		32		17		9		1		5
Other Activities(1)	17			24			18		35		(20)		16		16		23
Total	109			156			23		1,639		34		1,520		42		43
Adjusted EBIT / Adjusted EBIT Margin
Engineered Materials	209		15.3%	234		16.2%	220	16.6%	720	13.4%	183	14.3%	200	14.5%	213	14.8%	124	9.6%
Acetyl Chain	236		19.5%	321		24.2%	131	12.6%	695	16.4%	146	15.5%	187	17.6%	195	17.5%	167	15.0%
Other Activities(1)	(78)			(85)			(76)		(265)		(78)		(61)		(66)		(60)
Total	367		14.4%	470		17.1%	275	11.8%	1,150	12.0%	251	11.4%	326	13.5%	342	13.5%	231	9.7%

(1)Other Activities includes corporate SG&A expenses, and treasury operations, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

(2)Includes $11 million and $14 million of restructuring activities at our Mylar Specialty Films strategic affiliate during the three months ended September 30, 2026 and June 30, 2026, respectively, which are also included in Certain Items (see Table 8).

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)

Q3 '26 · Q2 '26 · Q1 '26 · 2025 · Q4 '25 · Q3 '25 · Q2 '25 · Q1 '25
(In $ millions, except percentages)
Depreciation and Amortization Expense(1)
Engineered Materials	102		101		104		441		105		115		112		109
Acetyl Chain	65		64		63		252		64		63		64		61
Other Activities(2)	14		14		13		50		15		13		12		10
Total	181		179		180		743		184		191		188		180
Operating EBITDA / Operating EBITDA Margin
Engineered Materials	311	22.7%	335	23.2%	324	24.5%	1,161	21.5%	288	22.6%	315	22.8%	325	22.5%	233	18.1%
Acetyl Chain	301	24.9%	385	29.0%	194	18.7%	947	22.4%	210	22.3%	250	23.6%	259	23.2%	228	20.4%
Other Activities(2)	(64)		(71)		(63)		(215)		(63)		(48)		(54)		(50)
Total	548	21.4%	649	23.6%	455	19.5%	1,893	19.8%	435	19.7%	517	21.4%	530	20.9%	411	17.2%

(1)Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.

(2)Other Activities includes corporate SG&A expenses, and treasury operations, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 3

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.